Outbreak of Covid-19

EPO hearings resuming

Update 10th May 2020 Operations at the EPO continue to be severely affected by the Covid-19 outbreak, however as restrictions are gradually being lifted in a number of European countries, the EPO has announced that oral proceedings in opposition and appeal cases can again...

German ratification void – UK is out

The German Federal Constitutional Court has ruled today that the German Parliament’s approval of the Agreement on a Unified Patent Court is void, as it has not been approved by the Parliament with the required two-thirds majority. The Court dismissed the complaint with regard to...

Ed Farrington appointed as partner

We proudly announce that European Patent Attorney Ed Farrington is now a shareholder and partner at Inspicos P/S. Ed joined Inspicos as an associate in 2010. Ed specializes in opposition and appeal proceedings at the European Patent Office, and regularly represents clients at oral...

New opportunities in Europe for generics and biosimilar companies

Ulla Klinge reports. An SPC (Supplementary Protection Certificate) is a right issued on the basis of a patent and a marketing authorisation for a drug,and which extends the period of protection for the patented drug for up to 5 years. Until now the holder...

Inspicos has been named Firm of the Year 2019 – having also won the prestigious award in 2018

The back-to-back success marks the third time that Inspicos has been named Firm of the Year in the category Denmark Patent Prosecution by Managing Intellectual Property (MIP). The awards for Europe, Middle East and Africa were presented at a gala ceremony in London on...